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Aleutian  disease  (AD)  of mink is characterized by a  systemic proliferation 
of  plasma  cells.  Secondary  to  this  plasma cell proliferation  there  is  marked 
hypergammaglobulinemia,  necrotizing  vasculitis,  proliferation  of  fibrillary 
polysaccharide  containing  material  in  the  mesangial  areas  of  the  glomeruli, 
and some thickening  of the glomerular capillary basement membranes (1--4). 
The extent of the tissue lesions is closely correlated with the degree of hyper- 
gammaglobulinemia in  A_D-affected  mink  (5).  A_D  is  readily  transmitted  to 
normal mink by cell-free ultrafiltrates, and the agent is sedimentable by ultra- 
centrifugation,  strongly suggesting that it is a  virus  (6,  7). 
The increased gamma globulin is initially heterogeneous electrophoretically, 
and  in  10  to  20 per  cent  of mink with  AD  followed for a  year,  the  gamma 
globulin  becomes  more  homogeneous,  resembling  the  globulin  in  human  or 
mouse myeloma. Mink developing the homogeneous globulin show Bence Jones 
proteinuria, but no myeloma-like bone lesions (8). 
This  infectious,  apparently viral,  disease  combines many of  the  serologic, 
cellular, and tissue changes in myeloma on one hand and in immunologically 
induced  vascular  and  renal  diseases  on  the  other.  The  present  studies  were 
undertaken in an attempt to define the pathogenetic mechanisms involved in 
AD, particularly the function, if any, of the gamma globulins and to compare 
the physical and metabolic characteristics of normal and AD gamma globulins. 
Materials and Methods 
Animals.--Ranch-raised mink were obtained from the Utah Mink Growers Cooperative, 
and were judged to be normal or to have AD on the basis of serum protein electrophoresis (5). 
Mink with a serum gamma globulin of 20 per cent or more of the total serum protein were 
considered to have AD. The presence or absence of AD was confirmed by gross and histologic 
examination of the tissues at the time of sacrifice of the mink. 
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Preparation of Proteins.--Normal  nfink serum was partially precipitated by the addition 
of ammonium  sulfate  to  50 per cent saturation.  Albumin was prepared  from the fraction 
soluble in  50 per cent  ammonium sulfate by a  continuous  molarity gradient elution from 
carboxymethylcellulose starting with sodium phosphate buffer 0.01 ~r pH 6.0.  Gamma globu- 
lin was prepared from the material insoluble in 50 per cent ammonium sulfate by dialysis 
against 0.0175 ~ sodium phosphate buffer pH 7.0 and elution from diethylaminoethylcellulose 
using thesamebuffer. Bovinegamma globulin (Armour Laboratories, Chicago, lot W30512) and 
egg albumin (Pentex, Inc., Kankakee, Illinois, lot 4) were obtained commercially, Megatkura 
crenulaZa hemocyanin was purified from the hemolymph by preparative ultracentrifugation. 
Proteins were trace-labeled with I TM (9). 
F_levtropkoreds and UltracenSrifugation.--Paper strip electrophoresis employed a  Beckman 
model R  system and  model RB analytrol scanner  (Beckman Instruments,  Inc.,  Palo  Alto 
California). Immunoelectrophoresis was done by the micromethod of Seheidegger  (10). 
Analytical ultracentrifugation was performed in a  Beckman model E  machine (Beckman 
Instruments,  Inc.) operated at 59,780 p~e~r using Schlieren optics. Photographic plates were 
measured with a microcomparator and sedimentation coefficients corrected to water at 20°C. 
Frepara$~ of Antiserums.--Anfiserums  to whole, normal, and AD-affected mink serums, 
gamma globulin, albumin, and fibrin were prepared in rabbits by 3 monthly injections of the 
material  in  Freund's  complete adjuvant,  followed  by  12  weekly injections of the soluble 
protein.  Antiserums were checked for specificity by immunoelectrophoresis. Rabbits and  a 
horse  were  injected  with  homogenates  of  AD-affected  mink  tissue  in  complete  Freund's 
adjuvant and the serums were subsequently absorbed with normal mink serum and tissues. 
Fluorescenl Antibody Technicuv.--The  fluorescent antibody  technique employed methods 
previously described (11).  Serums were labeled with fluorescein  isothiocyanate and absorbed 
with liver powder or eluted from diethylaminoethylcellulose with 0.05  ~  sodium phosphate 
buffer (12).  Frozen sections and cell smears from normal and AD-affected mink were fixed 
in alcohol-ether,  acetone,  or formalin. Ten AD-affected mink serums  and  5  normal  mink 
serums,  rabbit anti-mink gamma globulin, albumin, and fibrin, and rabbit and horse anti- 
AD-affected mink tissue were used as fluorescent  stains. 
Antibody DelerminaJions.--The antigen precipitating capacity of antiserums for hemocy- 
anin, bovine gamma globulin, and egg albumin was measured by the technique of Talmage 
and  Manrer  (13)  and antibody to Shigdla flexneri was measured by the agglutination of a 
0.025  per cent suspension of whole organisms. 
Complement Fixation.----Quantitative serum complement assays on mink serums were done 
by  the method  of Osler,  Strauss,  and  Mayer  (14).  Semiquantitative complement  fixation 
employing normal and AD-affected mink serums and normal and AD-affected tissue extracts 
as antigen were done by the LBCF method (15). 
Rheumatoid Factor Assay.--Assays  for rheumatoid factor were done by Dr.  Morris Ziff 
and Dr. H. H. Fudenberg employing sheep cells sensitized with normal mink gamma globulin 
which were reacted with normal and AD-affected mink serums. 
L. E. Cdl Preparation.--Lupus  erythematosus  (L.E.) cell preparations were done by the 
method of Hargraves (16) using 10 normal and 15 AD-affected mink blood samples. 
Serologic Test for Syph#is.--VDRL  and  Mazzini tests were performed on 4  normal and 
6 AD-affected mink serums. 
Serum Protein Half-Life.--Normal  and AD-affected mink were given potassium iodide in 
their drinking water throughout  the experiment.  Each animal received 2.0 #c of 1181 mink 
albumin or gamma globulin intraperitoneally, the injection contained 1 mg protein in 1 ml. 
The mink were counted in a whole body scintillation counter for 5 biologic half-lives of the 
protein. The protein half-life was determined by the slope of the semllogarithmic plot of dis- 
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determined by sulfosalicylic acid turbidity measurements of 24 hour urine specimens. Urine 
was examined for trichloroacetic add-predpitable  radioactivity. 
The E~ea of AD on Unrdated Antibody Formalion.--Fourteen  normal and 10 AD-affected 
mink were given one dose of complete Freund's adjuvant containing  10 mg each of hemo- 
cyanin, bovine gamma globulin, and egg albumin. The mink were bled 30 days after receiving 
the adjuvant. 
Fifty-four  normal mink were given 4 doses of incomplete Freund's adjuvant containing 
10 nag each of hemocyanin, bovine gamma globulin, and egg albumin, and 1 mg of Shigella 
flexneri whole killed organisms at 25 day intervals. At the time of the last injection of adjuvant 
33 of the mink were given AD-infectious material intraperitoneally.  Four months later  the 
mink receiving the AD virus had developed hypergammaglobulinemia of 50 per cent or more 
of the total serum protein.  The antibody levels of the AD-affected and normal mink were 
measured on the day of the virus inoculation and 4 months later to determine if AD and/or 
the  development  of hyperglobulinemia  would  affect  preexisting  and  continuing  unrelated 
antibody formation. 
RESULTS 
Serum Protein Half-Lires.--The results of the albumin and gamma globulin 
half-life studies  in normal  and  AD-affected mink  are  shown  in Table  I.  The 
mean half-life of albumin in 4 normal mink was 3.3 days, and in 4 AD-affected 
hypergammaglobulinemic mink it was 2.9 days; the mean values are not sig- 
nificantly different using the  t  test. The mean half-life of normal gamma glob- 
ulin in 5 normal mink was 3.45 days and in 5 AD affected mink it was 2.2 days, 
the difference of the means is highly significant using the  t  test  (P less than 
0.001).  There was no significant proteinuria  in this  group of mink,  and  there 
was no loss of trichloroacetic acid-precipitable  radioactivity in the urine. 
Ultracentrifugation  of  Mink  Serums.--Mink  gamma  globulin  from  either 
normal  or  AD-affected  mink  prepared  by  DEAE-cellulose  chromatography 
showed  a  single  homogeneous  peak  in  the  analytical  ultracentrifuge  with 
S20.w =  6.4  at  infinite  dilution.  Whole  diluted  serums  from 43  AD-affected 
mink and 10 normal mink were examined in the analytical ultracentrifuge. The 
AD-affected serums had  an average of 5.6 gin/100 ml  of gamma globulin as 
compared with 0.7 gin/100 ml for the normals. The serums from AD-affected 
mink showed a  large increase in the $20.,, =  6.4 component, and in addition, 
two components not seen in normal mink serums.  The abnormal components 
were  often  quite  heterogeneous  in  their  sedimentation  behavior  and  ranged 
from 9 to 17 and 22 to 25 S20.w, and these components represented up to 6  per 
cent of the total serum protein. The two abnormal components were markedly 
enriched  in  euglobulin  preparations.  In  the  presence  of 6  ~r urea  or pH  3.2 
glycine buffer  these  components  dissociated  to form 6.4S  and  18S units,  to- 
gether with a small amount of material lighter than 6S. Removal of urea from 
such a  dissociated preparation  resulted  in reappearance  of the two abnormal 
components, which, however, were more heterogeneous in their sedimentation 
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the two abnormal components found in AD-affected mink serums are protein- 
protein  complexes.  Immunoelectrophoresis  of  partially  purified  complexes 
indicated that they were composed, at least in part,  of gamma globulin. Text- 
fig. 1 shows 2 serums with complexes, their euglobulins demonstrating relative 
enrichment in the complexes, and the euglobulins in urea showing dissociation 
of the complexes. Text-fig. 2 shows a euglobulin with both types of complexes. 
Of the  43  AD  serums  tested,  31  had  22S to  25S  complexes,  21  had  9S  to 
17S complexes,  and  only 7  showed neither  type of complex.  The presence  or 
absence of complexes did not correlate with the presence or absence of vascu- 
TABLEI 
H~f-L~ ~  ~-Glob~inandAlbumm  in Yorm~ a~ Ale~n  D~ease-Aff~t~ Mmk 
Color/genotype 
Normal 
Black AA 
Pastel Aa 
Pastel Aa 
Pastel Aa 
Pastel Aa 
Meutian disease affected 
Pastel Aa 
Pastel Aa 
Pastel Aa 
Aleutian aa 
Pearl aa 
Total  protein  w-Globulin 
gm/1OOml 
7.4 
7.4 
7.3 
7.4 
7.3 
9.9 
9.4 
9.6 
9.2 
15.2 
iper cent  gm/lO0  ml 
11.7  0.86 
17.8  1.31 
14.4  1.05 
15.4  1.13 
14.5  1.06 
40.4  3.99 
45.4  4.26 
38.7  3.71 
44.5  4.09 
74.0  11.23 
Albumin 
per cent  gram///00 
58.2  4.31 
63.1  4.67 
68.6  5.01 
61.6  4.56 
66.5  4.85 
41.7  4.13 
32.8  3.08 
43.3  4.15 
38.7  3.56 
14.9  2.26 
Uri- 
nary 
protein 
loss 
rag/day 
7,  6 
0,  1 
4,  0 
4,  2 
4 
4,  10 
3,  2 
6,  3 
2,  9 
17 
Half-llfe 
"r-Glo- Albumin  bulin 
days  days 
3.1  2.8 
3.8  3.3 
3.25  3.7 
3.5  3.45 
3.6  -- 
2.3  3.1 
2.15  2.5 
2.1  2.8 
2.3  3.1 
2.1  -- 
lifts in  these mink.  Since all  animals  in this  group had advanced  glomerular 
lesions the complexes did not appear to be directly related to the development 
of this lesion. Mink serums with either or both types of complexes had normal 
levels of hemolytic complement. 
Fluorescent Antibody Results.--Arteritic lesions in AD-affected mink stained 
strongly with  anti-gamma  globulin,  and weakly or not at  all with  antifibrin 
and  antialbumin.  An example  of a  fluorescent  antibody stain  of an arteritic 
lesion is  shown in  Figs.  1 a  and  1 b,  together with  a  hematoxylin and  eosin 
stained  section of a  similar  vessel.  Glomeruli  affected by AD stained  weakly 
with all three antiserum proteins in a  mesangial pattern characteristic of non- 
specific proteinuria  (17). Ten AD and 5 normal fluorescent mink serums failed 
to stain  any cells  or tissues  of AD-affected or normal  mink,  including autol- 
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nates failed to show any consistent pattern of staining of AD mink cells com- 
patible  with  viral  particles  or  materials.  Results  were  identical  with  liver 
powder-absorbed  or  DEAE-eluted  fluorescent  antibody  preparations,  and 
likewise were identical using different methods of fixation. 
TEXT-FIG.  1.  Ultracentrifugal  pattern  of  two  Aleutian  disease-affected mink  serums 
showing the markedly elevated 6.4S peak and the presence of complexes which are indicated 
by the arrows. The complexes are 14S in the upper frames and heterogeneous in the lower. 
Euglobulin preparations  show marked enrichment in the complexes, and the euglobulin in 
6 ~ urea shows complete dissociation of the complexes to 6.4S units.  Sedimentation is from 
left to right and the time on the photograph is from the attainment of full operating speed. 
Complement Fixation.--Quantitative  serum  complement assays  showed  no 
difference between normal and AD-affected mink serums. The mean comple- 
ment of 114 mink was 150 C~H50 units with a  range of 53 to 250 C'H50 units. 
Semiquantitative complement fixation employing normal and AD-affected 
serums and infectious organ homogenates as antigen failed to show fixation of 
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Rheumatoid Factor Assay.--No  rheumatoid  factor activity was found using 
sheep cells sensitized with normal mink gamma globulin. 
L.E. Cell Preparations.--No  lupus  erythematosus  cells were found ir~ prepa- 
rations from normal or AD-affected mink. 
Serologic Tests for Syphilis.--No  reactivity of normal or  AD-affected  mink 
serums was found in VDRL or Mazzini tests. 
Gel Diffusion.--Double  diffusion  in  agar  gel  employing  rabbit  antiserums 
to  whole  AD-affected  mink  serum  which  subsequently  were  absorbed  with 
normal  mink  serum  and  as  antigens  either  the  immunizing  AD  serum  or  in- 
fectious tissue homogenate failed to show any reaction. 
TEXT-FIG.  2. Ultracentrifugal pattern of Aleutian disease-affected mink euglobulin in 0.15 M 
NaC1 showing complexes of 22S and 14S and normal components of 18S and 6.4S. Sedimenta- 
tion is from left to right. 
Egffect of AD on  Unrelated Antibody  Formation.--Thirty  days  after  a  single 
injection  of egg albumin,  bovine gamma globulin  (BGG),  and hemocyanin in 
complete  Freund's  adjuvant,  14 normal mink had an average response of 816 
/~g N  antigen precipitated/rnl  antiserum  to hemocyanin and  2.2/~g N  antigen 
precipitated/ml  antiserum  to  BGG.  Ten  AD-affected  mink  had  an  average 
response  of 224 #g N  antigen  precipitated/ml  antiserum  to hemocyanin,  and 
no  response  to  BGG.  Neither  group  made  a  detectable  response  to  egg  al- 
bumin.  The  mink  antibody  to  hemocyanin  was  6.4S  gamma  globulin  as  de- 
termined  by immunoelectrophoresis,  and showed a  range  of mobility as  great 
as  the  same  animal's  gamma  globulin  reacted  with  rabbit  anti-mink  gamma 
globulin. 
In the  group  of 54  mink  given  multiple  antigens  in  adjuvant  of which  33 
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globulinemic, the mink developing hypergammaglobulinemia did not show a 
corresponding  increase  in  antibody  titers  to  known  antigens  they  were  re- 
sponding to before and during AD infection. The AD agent caused at least a 
5-fold increase in the serum gamma globulin in this group of mink. The anti- 
body titers to hemocyanin and Shigella  fell comparably in both control mink 
and those becoming hypergammaglobulinemic due to the AD  agent with the 
exception of  1 control mink  which  kept  the  same  titer of antibody to each 
antigen. Six AD-affected mink and 2 controls showed rises in antibody levels 
to BGG of less  than double the level of the time the mink were given the AD 
agent,  while  the  remaining  46  showed  a  decrease in  anti-BGG titers.  As  in 
the  previous experiment, none  of the  mink  made  a  detectable antibody re- 
sponse to egg albumin. 
In all cases the normal mink receiving multiple antigens in adjuvant showed 
either no change in the amount of serum gamma globulin or only a  transient 
rise  in  serum  gamma  globulin  which  promptly  fell  upon  discontinuing  im- 
munization,  in  contrast  to  those either naturally  or  experimentally infected 
with  AD  agent which  remained  hypergammaglobulinemic for the  remainder 
of their lives. Hyperimmunization of experimental animals  usually does not 
produce hypergammaglobulinemia  of  the  magnitude  found  in  AD,  but  it  is 
possible in at least some instances (18). 
DISCUSSION 
Aleutian  disease  of mink presents  two  problems;  the  mechanism  of  the 
hypergammaglobulinemia,  and  the  pathogenesis  of  the  glomerular  and 
vascular  lesions  which  morphologically  resemble  some  lesions  induced  by 
immunologic injury. Although  there is  a  good statistical  correlation between 
the degree of hypergammaglobulinemia and  the extent of glomerular lesions 
and the presence of arteritis in AD (5), for the purposes of discussion of patho- 
genesis it will be useful to separate these two facets of the disease. 
Mink  with  AD  have  a  significantly  shortened  gamma  globulin  half-life, 
indicating that the hypergammaglobulinemia is due to overproduction rather 
than to decreased catabolism of the protein. This result is similar to the ob- 
servations in human myeloma and in hyperimmunized animals  where in the 
presence of hypergammaglobulinemia the gamma globulin half-life is usually 
shortened  (18,  19).  The lack  of effect of AD  on albumin  half-life is  also  in 
accord with studies on hypergammaglobulinemic rabbits (20), and is probably 
related  to  different  degradatory  mechanisms  for  these  two  serum  proteins. 
Analytical ultracentrifugation of AD affected mink serums showed that the 
increased "r-globulin was of the 6.4S type, and not macroglobulin, a result in 
accord with Kenyon and coworkers (21). The 6.4S mink 3'-globulin was shown 
in  this study to carry antibody activity to a  known antigen.  The finding of 
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consist at least in part of 6.4S  3'-globulin units,  in the serums of many mink 
with AD  is quite  similar to the demonstration of two classes of complexes in 
human rheumatoid arthritis serums (22,  23). 
Gorham and coworkers (24)  have shown that AD-affected mink do not have 
neutralizing  antibody  to  the  infectious  agent,  and  that  the  hypergamma- 
globulinemic serum itself is infectious to a level of l05 II)50/ml. Similarly in this 
study using  fluorescent antibody and  complement fixation methods,  no anti- 
body to the infectious agent has been detected in AD serums or in heterologous 
antiserums prepared against infectious material. 
The  possibility has  been raised  that  AD  is  an autoimmune  disease  (4,  6, 
25  27).  However,  fluorescent  AD  mink  serums  have failed  to  show  any re- 
action with normal or AD-affected mink tissues, including  autologous tissues, 
suggesting  that  the  increased  gamma  globulin  does  not  represent  auto-  or 
isoantibody to any of the antigens present in the various organs tested. Comple- 
ment  fixation  tests  yielded  negative  results.  Negative  results  were  obtained 
with L.E. cell,  rheumatoid factor, and syphilis serologic tests,  which  may  be 
positive in some human connective tissue diseases. Therefore, within the tech- 
nical limitations of the tests employed, no evidence for an autoimmune mech- 
anism in AD has been found. 
In an attempt to determine if the  AD  agent causes a  proliferation of and 
increased gamma globulin production by all preexisting clones of plasma cells, 
mink previously immunized to a  group of known antigens were given the AD 
agent in order to cause hypergammaglobulinemia. In no case did the antibody 
level to a known antigen rise in proportion to the rise in total gamma globulin 
level,  instead,  the  antibody levels more often fell coincident  with  the  rising 
gamma globulin.  This indicates  that  the  AD  agent does not  stimulate  indis- 
criminantly the  proliferation of preexisting clones  of plasma cells but  rather 
appears to have some specificity. 
Since it has not been possible to attribute the hypergammaglobulinemia of 
AD  to  production  of  antibody  against  the  infectious  agent,  the  host's  own 
tissues or to antigens to which the animal was responding prior to AD infec- 
tion, it may be that it results from events unrelated to immunologic processes. 
The AD  agent might  either  directly stimulate certain  plasma cell precursors 
to multiply, or cover or delete a locus responsible for controlling the prolifera- 
tive rate of the cells.  It has been found that 10 to 20 per cent of mink affected 
by AD for a year show a  transition from an electrophoretically heterogeneous 
hypergammaglobulinemia to an electrophoretically homogeneous, monoclonal 
type of hypergammaglobulinemia (8). The high rate of transformation into a 
monoclonal hypergammaglobulinemia together  with  the failure of AD  to  in- 
crease  preexisting  antibody  formation  is  strongly  in  favor of  the  AD  agent 
initially affecting a limited number of clones of plasma cells,  one of which may 
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The  vascular  lesions  of AD  show some morphologic  similarities  to those 
experimentally  produced  by  antigen-antibody  complexes.  In  experimental 
animals  it is known that amounts of antigen-antibody complexes too small to 
be detectable in the analytical ultracentrifuge are associated with the lesions of 
serum sickness  and at least one type of experimental glomerulonephritis  (28- 
30). In the AD-affected mink no direct evidence was found that the circulating 
protein-protein  complexes  were biologically harmful.  Thus,  the presence  of 
complexes  in  AD  is  similar  to  the situation  in  rheumatoid  arthritis,  where 
most of the patients having complexes have clinically  active disease and high 
rheumatoid factor levels,  but no direct evidence for a harmful biological role 
for the complexes  can be found (22, 23). 
Consumption of complement often occurs in the course of in r/vo antigen- 
antibody reactions associated with tissue injury. In serum sickness hemolytic 
complement often drops to less than half of the normal value coincident with 
the beginning  of immune elimination of the antigen (29). However, the amount 
of  complement  utilized  is  not  directly correlated  with  the  development  or 
severity of morphologic lesions. In nephrotoxic nephritis there is a sharp initial 
drop in complement level, and often a second transitory drop with the begin- 
ning of host response to the injected nephrotoxic serum, but normal comple- 
ment levels are present after 7 to 10 days although an immunologic reaction 
persists for up to 3 weeks (17). Complement levels in chronic complex induced 
glomerulonephritis were found not to be consistently decreased (31). It appears 
that  a  reduced hemolytic complement level is associated with acute in riro 
antigen-antibody reactions, but is not necessarily found in chronic in rivo anti- 
gen-antibody reactions. Thus,  the finding  of normal levels of hemolytic com- 
plement  in AD-affected mink does not rule out the possibility of a  chronic 
antigen-antibody reaction, which could conceivably cause tissue injury. 
The arteritic lesions in AD show localization  of serum gamma globulin,  but 
not fibrin  or albumin;  this  is similar  to the arteritic  lesions  in human peri- 
arteritis nodosa which show selective localization  of gamma globulin  (32). The 
affected vessels in both mink and man show fibrinoid necrosis by light micros- 
copy, but the cellular  infiltration  in AD  is almost  exclusively  mononuclear, 
while in the human periarteritis it is predominantly polymorphonuclear leuko- 
cytes, more similar  to the vasculitis in the Arthus reaction and serum sickness. 
The attraction  of a  different cell type in AD  as compared with periarteritis 
nodosa suggests a  difference  in pathogenesis of the lesions. 
The glomerular  lesions  of AD show only a mesangial localization  of serum 
proteins, with no preferential localization  of one protein. In contrast, complex 
induced nephritis and nephrotoxic serum nephritis show preferential deposition 
of gamma globulin and complement in the capillary walls  (17,  30).  AD also 
appears to differ from these other types of glomerular  injury in that it features 
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remainder of the capillary wall, while experimental complex-induced, nephro- 
toxic  serum-induced,  or  naturally  occurring  human  glomerulonephritis  pri- 
marily affects the peripheral glomerular capillary wall with variable damage 
to the mesangial areas. Again, this suggests that the glomerular lesions of AD 
may  have  a  pathogenesis  different  from  that  of  glomerular  injury  due  to 
known or suspected immunologic insult.  Fisher and coworkers (33)  have de- 
scribed  glomerular  changes  in  multiple  myeloma  which  have  considerable 
resemblance to the glomerular damage in AD, and they believe the changes 
to be quantitatively related to the level of serum protein. The close association 
of serum protein levels and presence of tissue lesions in AD would make this 
idea attractive, but it fails to explain the presence of arteritis, which to our 
knowledge does not  occur in  multiple  myeloma. An  alternative explanation 
for the parallel of the serum protein changes and tissue lesions is that the virus 
may directly infect glomerular and arterial cells as well as ceils of the plasma 
cell system, and that we see the result of similar degrees of infestation by the 
virus in different sites. 
Aleutian disease of mink has been suggested as a  good experimental model 
for human autoimmune or hypersensitivity diseases, primarily on the basis of 
some morphologic similarity of AD  to the  lesions  of this  group  of diseases 
(4,  6,  25-27). The present studies have failed to show any immunologic role 
for the increased gamma globulin of AD in the production of the vascular and 
renal lesions which would argue against any usual immunopathologic process. 
While this may be the result of limitations in methodology, comparable methods 
have indicated participation of ~,-globulin  in  human and experimental auto- 
immune  and  hypersensitivity diseases.  Thus,  until  the  pathogenetic  mech- 
anisms in AD become clearer, it would appear unwise to consider this naturally 
occurring infectious disease of mink as an experimental model for the study of 
human diseases of immunological origin. Further clarification of the nature of 
AD will require either in vitro cultivation of the infectious agent or an immuno- 
logic method of detecting the AD agent, neither of which has been achieved at 
this time. 
Sl.r~aARY 
Aleutian  disease-affected  mink,  which  are  markedly  hypergammaglobu- 
linemic, show a  decreased  half-life  of the serum  gamma globulin indicating 
that the hyperglobulinemia is due to increased production. No evidence that 
the  gamma globulin was  antibody to the infectious agent,  to autologous or 
isologous tissues, or to antigens the animal was responding to prior to develop- 
ment of the disease was obtained. The increased gamma globulin was found to 
be of the 6.4S variety, and gamma globulin containing protein-protein com- 
plexes of 9S to 17S and 22S to 25S classes were observed in sermns of affected 
mink. The findings are most consistent with the Aleutian disease virus  acting 
as a direct and somewhat selective stimulus to plasma cell proliferation. There 
is no evidence that the arterial and glomerular lesions of Aleutian disease have D.  D.  PORTER,  P.  J.  DIXON,  AND  A.  E.  LARSEN  899 
an immunologic pathogenesis. It seems possible that these vascular changes 
may be directly caused by the viral agent, or may be the result of the increased 
gamma globulin levels. 
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EXPLANATION OF PLATE 72 
FIGS. 1 a and 1 b. Renal arteries  from an Aleutian  disease-affected  mink. 
FIG.  1 a. The artery shows fibrinoid necrosis and a mononuclear  cell infiltration 
when examined by conventional histologic technique.  Hematoxylin and eosin stain, 
photomicrographed ×  102. 
FIG.  1 b.  Similar artery from the same mink stained  with fluorescent  anti-mink 
gamma globulin, with positive staining in the area of fibrinoid necrosis. Fluorescence 
micrograph,  )< 100. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 121  PLATE  72 
(Porter et al.: Gamma globulin  in Aleutian disease of mink) 